Bromide

Bromide

SCHEMBL910218

C=C[n+]1ccccc1.[Br-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7692579 1.00 BCHE (0.30)
Bromide SCHEMBL7692576 0.97
SCHEMBL33807 0.96
Water SCHEMBL17291886 0.93
Bromide SCHEMBL7692577 0.93
Bromide SCHEMBL5435801 0.93
Iodide SCHEMBL1895751 0.93
Hydrochloric Acid SCHEMBL1226867 0.93
Hydrochloric Acid SCHEMBL524740 0.93
Fluoride Ion SCHEMBL324687 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174860-B2 Stimulant sensitive flocculation and consolidation NEWCASTLE INNOVATION LIMITED (AU) 2015-11-03 US claimed
US-20120160776-A1 STIMULANT SENSITIVE FLOCCULATION AND CONSOLIDATION THE UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES LIMITED (AU) 2012-06-28 US claimed
WO-2009089570-A1 FLOTATION AIDS AND PROCESSES FOR USING THE SAME THE UNIVERSITY OF MELBOURNE (AU) 2009-07-23 WO claimed
US-20080190860-A1 Stimulant Sensitive Flocculation and Consolidation UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES LIMITED (AU) 2008-08-14 US claimed
WO-2005021129-A1 STIMULANT SENSITIVE FLOCCULATION AND CONSOLIDATION THE UNIVERSITY OF NEWCASTLE RESEARCH ASSOCIATES LIMITED (AU) 2005-03-10 WO claimed
WO-2024137567-A1 WET WIPE THE PROCTER & GAMBLE COMPANY (US) 2024-06-27 WO disclosed
EP-4240319-A1 LOW SURFACTANT COSMETIC COMPOSITION COMPRISING A CATIONIC POLYMER The Procter & Gamble Company (US) 2023-09-13 EP disclosed
WO-2022098617-A1 LOW SURFACTANT COSMETIC COMPOSITION COMPRISING A CATIONIC POLYMER THE PROCTER & GAMBLE COMPANY (US) 2022-05-12 WO disclosed
EP-3993828-A1 NUCLEIC ACID BASED COMBINATION VACCINES CureVac AG (DE) 2022-05-11 EP disclosed
WO-2021239880-A9 NUCLEIC ACID BASED COMBINATION VACCINES CUREVAC AG (DE) 2022-01-13 WO disclosed
WO-2021239880-A1 NUCLEIC ACID BASED COMBINATION VACCINES CUREVAC AG (DE) 2021-12-02 WO disclosed
EP-3226271-B1 ELECTROCHEMICAL DEVICE RISE RES INSTITUTES OF SWEDEN AB (SE) 2021-03-17 EP disclosed
WO-2002085542-A8 ANTIMICROBIAL POLYMERIC SURFACES MASSACHUSETTS INST TECHNOLOGY (US) 2002-12-27 WO disclosed
WO-2002085542-A1 ANTIMICROBIAL POLYMERIC SURFACES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-10-31 WO disclosed
WO-2002085542-A1 ANTIMICROBIAL POLYMERIC SURFACES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-10-31 WO disclosed
EP-1003527-A1 POLYNUCLEOTIDE COMPOSITIONS SUPRATEK PHARMA, INC. (CA) 2000-05-31 EP disclosed
WO-1999006055-A1 POLYNUCLEOTIDE COMPOSITIONS SUPRATEK PHARMA INC. (CA) 1999-02-11 WO disclosed
US-5244768-A Manufacturing process for an electrophotographic toner FUJI XEROX CO., LTD. (JP) 1993-09-14 US disclosed
US-5101218-A Water insoluble cationic polymers as ink receivers CANON KABUSHIKI KAISHA (JP) 1992-03-31 US disclosed
US-4877680-A WATER-INSOLUBLE POLYMER COMPLEX FROM ACIDIC AND BASIC POLYMERS; CATIONIC RESIN CANON KABUSHIKI KAISHA (JP) 1989-10-31 US disclosed